Cytokinetics
CYTK
#2426
Rank
A$11.06 B
Marketcap
A$90.49
Share price
-3.55%
Change (1 day)
20.09%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -A$1.17 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$87.21 Million. In 2024 the company made an earning of -A$0.9 Billion a decrease over its 2023 earnings that were of -A$0.8 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.17 Billion30.88%
2024 -A$0.9 Billion12.03%
2023 -A$0.8 Billion35.3%
2022 -A$0.59 Billion80.65%
2021 -A$0.33 Billion69.15%
2020 -A$0.2 Billion4.6%
2019 -A$0.19 Billion14.49%
2018 -A$0.17 Billion-16.83%
2017 -A$0.2 Billion-812.8%
2016 A$27.11 M-147.81%
2015 -A$56.73 Million156.05%
2014 -A$22.16 Million-56.56%
2013 -A$51.01 Million-16.48%
2012 -A$61.07 Million-15.65%
2011 -A$72.4 Million-3.24%
2010 -A$74.83 Million-308.68%
2009 A$35.85 M-141.87%
2008 -A$85.63 Million0.21%
2007 -A$85.45 Million-7.91%
2006 -A$92.79 Million37.42%
2005 -A$67.52 Million16.13%
2004 -A$58.14 Million-19.29%
2003 -A$72.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.10 B-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$46.98 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.42 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.47 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.67 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA